SHARE
TAGS
<< Back to listing
Vote up (8) down (5)
Second Thought | How Gilead monetised the pandemic

Second Thought | How Gilead monetised the pandemic

(10:30) Remdesivir, produced by Gilead from taxpayer-funded research, is the only effective treatment so far for COVID-19. But at $2000 - $3000 per patient, why is it so expensive?
Second Thought YT channel Jul 10, 2020

You can comment as a guest, but registering gives you added benefits

Add your comment
Submit as guest (your name)

Copy code captcha


Submit as member (username / password)

CANCEL
Guest: CleaningUp (73 days ago)

Are the profiteers and their investors old enough to have registered with the Selective Service?  I think that they would benefit from a term as porters in VA hospitals.

Original comment

Are the profiteers and their investors old enough to have registered with the Selective Service?  I think that they would benefit from a term as porters in VA hospitals.

Add your reply
Submit as guest (your name)

Copy code captcha


Submit as member (username / password)

CANCEL
Guest: (73 days ago)
Latest comment:

Dexamethasone

30% life saving, and the more ill you are, the better it works!

Look it up, this is how UK pharma companies work.

USA, get a grip!

Original comment
Latest comment:

Dexamethasone

30% life saving, and the more ill you are, the better it works!

Look it up, this is how UK pharma companies work.

USA, get a grip!

Add your reply
Submit as guest (your name)

Copy code captcha


Submit as member (username / password)

CANCEL
RELATED POSTS
Kyle Kulinski | Big pharma flip Trump
Kyle Kulinski | Big pharma flip Trump
The Hill | How big pharma is profiteering from the pandemic
The Hill | How big pharma is profiteering from the pandemic
Is every cable news network "owned" by big pharma?
Is every cable news network "owned" by big pharma?
NowThis | Andrew Yang, on how he'll beat Big Pharma
NowThis | Andrew Yang, on how he'll beat Big Pharma
NowThis | Just ask your Big Pharma guys that
NowThis | Just ask your Big Pharma guys that